These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10711852)

  • 41. Oral Chemotherapy Adherence: A Novel Nursing Intervention Using an Electronic Health Record Workflow
.
    Rodriguez G; Utate MA; Joseph G; St Victor T
    Clin J Oncol Nurs; 2017 Apr; 21(2):165-167. PubMed ID: 28315532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Issues related to overadherence to oral chemotherapy or targeted agents.
    Spoelstra SL; Given BA; Given CW; Grant M; Sikorskii A; You M; Decker V
    Clin J Oncol Nurs; 2013 Dec; 17(6):604-9. PubMed ID: 24113679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Safe chemotherapy in the home environment.
    Chavis-Parker P
    Home Healthc Now; 2015 May; 33(5):246-51; quiz 252-3. PubMed ID: 25943215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotherapy dose intensity and quality cancer care.
    Lyman GH
    Oncology (Williston Park); 2006 Dec; 20(14 Suppl 9):16-25. PubMed ID: 17370925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metronomic dosing of chemotherapy: applications in pediatric oncology.
    Stempak D; Seely D; Baruchel S
    Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Challenges in prescribing drugs for children with cancer.
    Paolucci P; Jones KP; del Carmen Cano Garcinuno M; Catapano M; Iolascon A; Ceci A
    Lancet Oncol; 2008 Feb; 9(2):176-83. PubMed ID: 18237852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survival.
    Gisselbrecht C
    Eur J Cancer; 1994; 30A Suppl 3():S30-3. PubMed ID: 7535070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
    Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
    Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extending the quality and safety agenda from parenteral to oral chemotherapy.
    Krzyzanowska MK; Powis M
    J Oncol Pract; 2015 May; 11(3):198-201. PubMed ID: 25829521
    [No Abstract]   [Full Text] [Related]  

  • 50. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.
    Neuss MN; Polovich M; McNiff K; Esper P; Gilmore TR; LeFebvre KB; Schulmeister L; Jacobson JO
    Oncol Nurs Forum; 2013 May; 40(3):225-33. PubMed ID: 23619103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative bioavailability of pediatric oral solution and tablet formulations of trametinib in adult patients with solid tumors.
    Cox DS; Allred A; Zhou Y; Infante JR; Gordon MS; Bendell J; Jones S; Burris H; Orford K
    Clin Pharmacol Drug Dev; 2015 Jul; 4(4):287-94. PubMed ID: 27136909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral administration of antineoplastic agents: the challenges for healthcare professionals.
    Tadic D; Spasojevic IB; Tomasevic ZI; Dejanovic SD
    J BUON; 2015; 20(3):690-8. PubMed ID: 26214619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nursing Application of Oral Chemotherapy Safety Standards:An Informal Survey.
    LeFebvre KB; Felice TL
    Clin J Oncol Nurs; 2016 Jun; 20(3):258-62. PubMed ID: 27206292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
    Mahmud F; Chung SW; Alam F; Choi JU; Kim SW; Kim IS; Kim SY; Lee DS; Byun Y
    J Control Release; 2017 Mar; 249():42-52. PubMed ID: 28093298
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current practice patterns for oral chemotherapy: results of a national survey.
    Roop JC; Wu HS
    Oncol Nurs Forum; 2014 Mar; 41(2):185-94. PubMed ID: 24370897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ABI 007.
    Drugs R D; 2004; 5(3):155-9. PubMed ID: 15139776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer chemotherapy: with or without food?
    Jatoi A
    Support Care Cancer; 2010 May; 18 Suppl 2():S13-6. PubMed ID: 19484482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time to get serious about improving the safety of oral chemotherapy.
    Krzyzanowska MK
    J Oncol Pract; 2013 Mar; 9(2 Suppl):1s-2s. PubMed ID: 24135009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The "new" era of oral antineoplastic drug therapy: revisiting "old" concerns.
    Markman M
    Curr Oncol Rep; 2006 Sep; 8(5):317-8. PubMed ID: 16901392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.